Ketamine clinics have multiplied across America faster than the DEA (Drug Enforcement Administration) can monitor them. Many operate through telehealth, bill insurance in questionable ways, and prescribe ketamine off-label (for uses the FDA hasn't officially approved). The DEA's databases already flag suspicious billing patterns. Congress is paying attention to fraud in behavioral health. When the DEA acts, it usually files criminal charges, imposes fines, or revokes a clinic's license to prescribe.
Ketamine clinic expansion has structurally outpaced DEA oversight capacity. Medicaid and insurance billing irregularities at telehealth-adjacent ketamine operations are already flagged in federal diversion databases. Congressional fraud-and-abuse scrutiny of behavioral health billing reinforces DEA enforcement mandate. Base rate of DEA clinic actions has increased annually since 2022. Resolves on public DEA press release, court filing, or DEA registration revocation notice.